Prof. Çetin Ordu, M.D.

2016
TC Demiroğlu Science University
Associate Professor

2014
Gayrettepe Florence Nightingale Hospital
Medical Oncology

2012 – 2016
Istanbul Science University
Assistant Professor

2011 – 2013
Republic of Turkey Ministry of Health
Specialist

2007 – 2010
Yeditepe University
Medical Oncology Specialist

2001 – 2007
Akbank Tekaut Fund Health Center
Internal Medicine Specialist

2000 – 2001
Yapı Kredi Health Center
Internal Medicine Specialist

1998 – 1999
Republic of Turkey Ministry of National Defense
Internal Medicine Specialist

1992 – 1996
Haseki Training and Research Hospital
Internal Medicine Specialist

1992 – 1997
Republic of Turkey Ministry of Health
Assistant Doctor

1991 – 1992
Republic of Turkey Ministry of Health
Emergency Clinic

• Breast Cancer

• Lung Cancer

• Genito Urinary System Cancers

2010
Yeditepe University
Medical Oncology Specialization Training

1996
Haseki Training and Research Hospital
Specialization Training

1991
Istanbul University Cerrahpaşa Faculty of Medicine

1. Çelebi Filiz, Nur Pilancı Kezban, Ordu Çetin, Ağacayak Filiz, Alço Gül, İlgün Serkan, Sarsenov Dauren, Erdoğan Zeynep,  Özmen Vahit (2015) The role of ultrasonographic findings to predict molecular subtype, histologic grade, and hor mone receptor status of breast cancer, Diagn Interv Radiol. 2015 Nov-Dec; 21(6): 448–453. 

2. Muhyettin Omar, Ozgur Tanriverdi, Suna Cokmert, Esin Oktay, Ozlem Yersal, Kezban NurPilancı, Serkan Menekse, Mu harrem Kocar, Cenk Ahmet Sen, Cetin Ordu, Gamze Göksel, Nezih Meydan, Sabri Barutca, Turkish Descriptive Onco logical Researches Group, Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as  poor prognostic factors in lung cancerClin Respir J. 2018 Mar;12(3):922-929 

3. Filiz İzci, Dauren Sarsanov, Zeynep İyigün Erdogan, Ahmet Serkan İlgün, Esra Çelebi, Gül Alço, Nazmiye Kocaman, Çetin  Ordu, Alper Öztürk, Tomris Duymaz, Kezban Nur Pilavcı, Filiz Elbüken, Filiz Ağaçayak, Fatma Aktepe, Gizem Ünveren,  Gözdem Özdem, Yeşim Eralp, Vahit ÖzmenImpact of Personality Traits, Anxiety, Depression and Hopelessness Levels  on Quality of Life in the Patients with Breast Cancer,Eur J Breast Health. Apr 2018; 14(2): 105–111. 

4. Zeynep Erdogan Iyigun, Tomris Duymaz, Ahmet Serkan Ilgun, Gul Alco, Cetin Ordu, Dauren Sarsenov, Ayse Esra Aydin,  Filiz Elbuken Celebi, Filiz Izci, Yeşim Eralp, Vahit Ozmen Preoperative Lymphedema-Related Risk Factors in Early-Stage  Breast CancerLymphatic Research and BiologyVol.16, No. one 

5. Leyla Kilic, Cetin Ordu, Ibrahim Yildiz, Fatma Sen, Serkan Keskin, Rumeysa Ciftci, Kezban Nur Pilanci, Current adjuvant  treatment modalities for gastric cancer: From history to the future, World J Gastrointest Oncol. 2016 May 15; 8(5):  439–449. 

6. Ozgur Tanriverdi, Nilufer Avci, Esin Oktay, Serdar Kalemci, Kezban Nur Pilanci, Suna Cokmert, Serkan Menekse, M  harrem Kocar, Cenk Ahmet Sen, Tulay Akman, Cetin Ordu, Gamze Göksel, Nezih Meydan, Sabri Barutca, Pretreatment  Serum Albumin Level is an Independent Prognostic Factor in Patients with Stage IIIB Non-Small Cell Lung Cancer:  A Study of the Turkish Descriptive Oncological Researches GroupAsian Pac J Cancer Prev. 2015;16(14):5971-6. doi:  10.7314/apjcp.2015.16.14.5971 

7. Mine Özkan, Nazmiye Yıldırım, Rian Dışçi, Ahmet Serkan İlgün, Dauren Sarsenov, Gül Alço, Fatma Aktepe, Nesiba Kaly oncu, Filiz İzci, Derya Selamoğlu, Çetin Ordu, Kezban Nur Pilancı, Zeynep İyigün Erdoğan, Yeşim Eralp, Vahit Özmen,  Roles of Biopsychosocial Factors in the Development of Breast CancerEur J Breast Health. 2017 Oct; 13(4): 206–212. 

8. Nilufer Avci, Murat Hayar, Ozgur Altmisdortoglu, Ozgur Tanriverdi, Adem Deligonul, Cetin Ordu, Turkkan Evrensel Smoking habits are an independent prognostic factor in patients with lung cancer Clin Respir J. 2015. https://doi. org/10.1111/crj .12386 

9. Serkan İlgün, Dauren Sarsenov, Zeynep Erdoğan, Cetin Ordu, Filiz Celebi, Kezban Nur Pulancı, Alper Özturk, Derya  Selamoğlu, Gül Alço, Fatma Aktepe, Yeşim Eralp, Sıtkı Tuzlali, Vahit Özmen Receptor discordance rate and its effects  on survival in primary and recurrent breast cancer patients JBUON 2016; 21(6): 1425-1432 

10. Kezban Nur Pilancı, Sezer Saglam, Alper Okyar, Serap Yucel, Zeliha Pala-Kara, Cetin Ordu, Esat Namal, Rumeysa  Ciftci, Ulkuhan Iner-Koksal, Esra Kaytan-Saglam Chronomodulated oxaliplatin plus Capecitabine (XELOX) as a first line  chemotherapy in metastatic colorectal cancer: A Phase II Brunch regimen studyCancer Chemother Pharmacol 78,  143–150 (2016). https://doi.org/10.1007/s00280-016-3067-x